Toxoplasma-induced activities of peritoneal and spleen natural killer cells from beige mice against thymocytes and YAC-1 lymphoma targets.

T Kamiyama
Author Information

Abstract

Homozygous (bg/bg) and heterozygous (bg/+) beige mice were infected with Toxoplasma gondii, and splenic and peritoneal natural killer (NK) cell activities were assayed against YAC-1 lymphoma (NK-YAC) and thymocyte (NK-THY) targets. Although uninfected bg/bg mice were devoid of NK-YAC activity when compared with bg/+ mice, NK-THY activity was at a completely normal level. Both effector cells showed NK-1.2+ Thy-1.2 +/- asialo GM1+ asialo GM2+ phenotype. T. gondii infection induced a marked augmentation in splenic NK-YAC activity of bg/+ mice, whereas a slight increase was shown in the bg/bg mouse spleen cells. On the other hand, the infection did not change the splenic NK-THY activity of either strain of mice. An increased expression of Thy-1.2 antigen was shown on both NK-THY and NK-YAC effector cells from the infected mouse spleen. The T. gondii-induced augmentation was dramatic in the peritoneal cavity of the both mice. The activated peritoneal NK cells were of the NK-1.2- Thy-1.2+ asialo GM1 +/- asialo GM2+ phenotype and were considered to be generated from functionally inactive peritoneal cells. Splenic effector cells obtained from the infected mice were selectively depleted with target cell monolayer, whereas peritoneal cells from the infected mice were strongly absorbed by the target monolayers without selectivity. A weak but significant interferon (IFN) titer was detected in the peritoneum, but not in the spleen, of the infected mice. Most of the IFN titer was acid labile. Treatment with anti-IFN-alpha/beta resulted in partial decline of both NK and IFN activities of bg/bg mice, but not bg/+ mice. Thus, involvement of both IFN-alpha/beta and IFN-gamma in the generation of peritoneal NK cells and IFN-independent augmentation of splenic NK cells in toxoplasmosis were suggested.

References

  1. Proc Soc Exp Biol Med. 1966 Dec;123(3):862-6 [PMID: 4289528]
  2. Infect Immun. 1983 Nov;42(2):789-95 [PMID: 6417022]
  3. Genetics. 1972 Nov;72(3):451-60 [PMID: 4643821]
  4. Infect Immun. 1974 Jul;10(1):88-91 [PMID: 4601767]
  5. J Immunol. 1975 Oct;115(4):1151-8 [PMID: 809507]
  6. Clin Exp Immunol. 1975 Oct;22(1):167-76 [PMID: 1082393]
  7. J Immunol. 1976 Aug;117(2):381-7 [PMID: 950460]
  8. J Infect Dis. 1976 Dec;134(6):610-23 [PMID: 826595]
  9. J Infect Dis. 1977 Mar;135(3):408-13 [PMID: 850078]
  10. J Immunol. 1979 Jan;122(1):175-81 [PMID: 310826]
  11. Nature. 1979 Mar 29;278(5703):451-3 [PMID: 313007]
  12. Nature. 1980 Apr 17;284(5757):622-4 [PMID: 7366733]
  13. Scand J Immunol. 1980;11(4):363-7 [PMID: 6155687]
  14. J Immunol. 1980 Oct;125(4):1551-7 [PMID: 6157740]
  15. Cancer Res. 1980 Nov;40(11):3934-9 [PMID: 7471044]
  16. Int J Cancer. 1980 Dec 15;26(6):789-97 [PMID: 7216547]
  17. J Immunol. 1981 May;126(5):1985-9 [PMID: 7217676]
  18. Microbiol Immunol. 1980;24(11):1109-20 [PMID: 6163946]
  19. Parasite Immunol. 1980 Winter;2(4):277-92 [PMID: 7220074]
  20. J Immunol. 1981 Sep;127(3):1126-30 [PMID: 6790614]
  21. J Exp Med. 1981 Aug 1;154(2):306-17 [PMID: 7264561]
  22. J Exp Med. 1981 Sep 1;154(3):750-62 [PMID: 6168724]
  23. J Immunol. 1981 Dec;127(6):2296-300 [PMID: 6170696]
  24. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5104-8 [PMID: 6272291]
  25. J Immunol. 1982 Mar;128(3):1070-5 [PMID: 7057032]
  26. J Immunol. 1982 Mar;128(3):1482-4 [PMID: 6173440]
  27. Int J Cancer. 1981 Dec;28(6):739-46 [PMID: 6800966]
  28. J Immunol. 1982 Apr;128(4):1577-83 [PMID: 6120974]
  29. Med Microbiol Immunol. 1982;170(3):155-72 [PMID: 6176843]
  30. Infect Immun. 1982 May;36(2):628-36 [PMID: 6177634]
  31. J Immunol. 1982 Aug;129(2):824-8 [PMID: 7086145]
  32. Cell Immunol. 1982 May 15;69(2):330-46 [PMID: 6980721]
  33. Infect Immun. 1982 Dec;38(3):1208-16 [PMID: 6218091]
  34. Microbiol Immunol. 1982;26(9):831-42 [PMID: 7154991]
  35. Infect Immun. 1983 Apr;40(1):1-7 [PMID: 6219954]
  36. Nat New Biol. 1972 Jan 12;235(54):48-50 [PMID: 4109405]

MeSH Term

Animals
Ascitic Fluid
Binding Sites
Cell Line
Cytotoxicity, Immunologic
Female
Immunosorbent Techniques
Interferons
Killer Cells, Natural
Lymphoma
Male
Mice
Mice, Inbred C57BL
Mice, Inbred CBA
Phenotype
Spleen
T-Lymphocytes
Toxoplasmosis, Animal

Chemicals

Interferons

Word Cloud

Created with Highcharts 10.0.0micecellsperitonealinfectedNKbg/bgbg/+splenicNK-YACNK-THYactivityasialospleenactivitieseffectorThy-1augmentationIFNbeigegondiinaturalkillercellYAC-1lymphomatargetsNK-12+2+/-GM2+phenotypeTinfectionwhereasshownmousetargettiterHomozygousheterozygousToxoplasmaassayedthymocyteAlthoughuninfecteddevoidcomparedcompletelynormallevelshowedGM1+inducedmarkedslightincreasehandchangeeitherstrainincreasedexpressionantigengondii-induceddramaticcavityactivated2-GM1consideredgeneratedfunctionallyinactiveSplenicobtainedselectivelydepletedmonolayerstronglyabsorbedmonolayerswithoutselectivityweaksignificantinterferondetectedperitoneumacidlabileTreatmentanti-IFN-alpha/betaresultedpartialdeclineThusinvolvementIFN-alpha/betaIFN-gammagenerationIFN-independenttoxoplasmosissuggestedToxoplasma-inducedthymocytes

Similar Articles

Cited By